CD79A and systemic lupus erythematosus: Cell cycle, DNA replication, Parkinson’s disease, pyrimidine metabolism, and ribosome pathways were activated in patients with high-risk scores, while allograft rejection, asthma, the intestinal immune network for IgA production, primary immunodeficiency, and systemic lupus erythematosus pathways were activated in patients with low-risk scores.